Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs EMMESSAR CHM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS EMMESSAR CHM SUVEN PHARMACEUTICALS/
EMMESSAR CHM
 
P/E (TTM) x 134.2 26.3 510.7% View Chart
P/BV x 15.9 3.1 517.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SUVEN PHARMACEUTICALS   EMMESSAR CHM
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-24
EMMESSAR CHM
Mar-24
SUVEN PHARMACEUTICALS/
EMMESSAR CHM
5-Yr Chart
Click to enlarge
High Rs76748 1,608.3%   
Low Rs37521 1,777.3%   
Sales per share (Unadj.) Rs41.31.1 3,720.6%  
Earnings per share (Unadj.) Rs11.81.5 786.4%  
Cash flow per share (Unadj.) Rs13.91.7 822.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs80.514.8 543.6%  
Shares outstanding (eoy) m254.575.00 5,091.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.830.9 44.7%   
Avg P/E ratio x48.422.9 211.1%  
P/CF ratio (eoy) x41.020.3 202.0%  
Price / Book Value ratio x7.12.3 305.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m145,357172 84,588.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,35910 14,202.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,5146 189,433.2%  
Other income Rs m61920 3,107.7%   
Total revenues Rs m11,13325 43,708.6%   
Gross profit Rs m4,058-11 -37,540.5%  
Depreciation Rs m5461 55,710.2%   
Interest Rs m750 745,100.0%   
Profit before tax Rs m4,0578 49,898.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0541 167,287.3%   
Profit after tax Rs m3,0038 40,037.5%  
Gross profit margin %38.6-194.7 -19.8%  
Effective tax rate %26.07.7 335.3%   
Net profit margin %28.6135.1 21.1%  
BALANCE SHEET DATA
Current assets Rs m13,62369 19,868.0%   
Current liabilities Rs m2,0615 38,878.3%   
Net working cap to sales %110.01,140.1 9.6%  
Current ratio x6.612.9 51.1%  
Inventory Days Days3189 3,504.3%  
Debtors Days Days464147 316.4%  
Net fixed assets Rs m9,90919 51,852.4%   
Share capital Rs m25550 509.5%   
"Free" reserves Rs m20,23224 84,090.3%   
Net worth Rs m20,48774 27,677.2%   
Long term debt Rs m00-   
Total assets Rs m23,53288 26,836.0%  
Interest coverage x55.4814.0 6.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.1 705.9%   
Return on assets %13.18.6 152.7%  
Return on equity %14.710.1 144.7%  
Return on capital %20.211.0 183.4%  
Exports to sales %046.0 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA3 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,8573 424,089.8%   
Fx outflow Rs m2,1190-   
Net fx Rs m8,7373 341,300.8%   
CASH FLOW
From Operations Rs m3,5856 55,578.8%  
From Investments Rs m-3,623-6 56,250.5%  
From Financial Activity Rs m-138NA-  
Net Cashflow Rs m-1760 -1,757,200.0%  

Share Holding

Indian Promoters % 0.0 59.5 -  
Foreign collaborators % 50.1 0.0 -  
Indian inst/Mut Fund % 27.7 0.2 13,825.0%  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.9 40.5 123.3%  
Shareholders   69,337 6,936 999.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SUVEN PHARMACEUTICALS vs EMMESSAR CHM

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SUVEN PHARMACEUTICALS vs EMMESSAR CHM Share Price Performance

Period SUVEN PHARMACEUTICALS EMMESSAR CHM S&P BSE HEALTHCARE
1-Day 0.30% 0.69% 0.67%
1-Month 2.24% -2.38% -0.80%
1-Year 109.43% 74.02% 42.82%
3-Year CAGR 37.19% 21.72% 20.13%
5-Year CAGR 50.10% 34.10% 26.10%

* Compound Annual Growth Rate

Here are more details on the SUVEN PHARMACEUTICALS share price and the EMMESSAR CHM share price.

Moving on to shareholding structures...

The promoters of SUVEN PHARMACEUTICALS hold a 50.1% stake in the company. In case of EMMESSAR CHM the stake stands at 59.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUVEN PHARMACEUTICALS and the shareholding pattern of EMMESSAR CHM.

Finally, a word on dividends...

In the most recent financial year, SUVEN PHARMACEUTICALS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

EMMESSAR CHM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SUVEN PHARMACEUTICALS, and the dividend history of EMMESSAR CHM.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.